Nivolumab versus Docetaxel in a Predominantly Chinese Patient Population with Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 078 Randomised Phase 3 Clinical Trial

2018 ◽  
Author(s):  
Yi-Long Wu ◽  
Shun Lu ◽  
Ying Cheng ◽  
Caicun Zhou ◽  
Jie Wang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Patient Population ◽  
Chinese Patient ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated

scholarly journals Phase 3 trial comparing nab-paclitaxel with docetaxel for previously treated advanced non–small cell lung cancer

2021 ◽  
Author(s):  
Yasuto Yoneshima ◽  
Satoshi Morita ◽  
Masahiko Ando ◽  
Atsushi Nakamura ◽  
Shunichiro Iwasawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated

Phase II clinical trial of didemnin B in previously treated small cell lung cancer

1994 ◽  
Vol 12 (3) ◽  
pp. 243-249 ◽  
Author(s):  
Dong M. Shin ◽  
Paul Y. Holoye ◽  
Arthur Forman ◽  
Rodger Winn ◽  
Roman Perez-Soler ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Didemnin B ◽  
Small Cell Lung ◽  
Previously Treated

scholarly journals Atezolizumab in Japanese Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study

2018 ◽  
Vol 19 (4) ◽  
pp. e405-e415 ◽  
Author(s):  
Toyoaki Hida ◽  
Reiko Kaji ◽  
Miyako Satouchi ◽  
Norihiko Ikeda ◽  
Atsushi Horiike ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Subgroup Analysis ◽  
Japanese Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document